chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: PNC20, PNC20
Symptoms: Immunoglobulin therapy, Intensive care, Intermittent claudication, Lumbar puncture abnormal, Muscular weakness
Clinical narrative: On 03/06/24, 63 yo M presented to Medicine clinic as a new patient evaluation. Pt's PMHx included HTN, CVA in 2012, DM-II, dysphagia, pilar cyst, and atherosclerotic PVD with intermittent claudication. During visit, pt was ordered and administered Pneumococcal (PCV20) (>=6WKS) vaccine (Prevnar 20). Per immunization record, pt received 0.5 mL in left deltoid at 1556 (Lot #HG7740, Exp: 4/30/2025, NDC #0005-2000-01). Pt was referred to Vascular Surgery for PVD, GI for dysphagia, and GSU for Pilar cyst. On 03/13, pt seen by Vascular Surgery. Assessment was unremarkable with no recommended intervention for nonlimb threatening right lower extremity claudication. MD did discuss smoking cessation. There was no documentation of any other pt symptoms or problems. On 03/16/24, pt presented to ED with c/o numbness and tingling in lower extremities with difficulty standing/walking. Neurology consulted and MRI ordered. Due to progressing weakness through arms and trunk, pt admitted to ICU for work up for Guillain Barre Syndrome. On 03/17, pt intubated and started on IVIG. 03/18 LP confirmed GBS diagnosis. On 03/20, pt received fourth and final dose of IVIG. Pt offered tracheostomy, but both pt and family declined. Psych and Palliative Care consults completed. Pt's condition continued to decline with new diagnosis of aspiration pneumonia on 03/28. Pt started on antibiotics. PLEX treatment started on 04/02. PLEX stopped on 04/04 due to fever. Pt transitioned to comfort care. Pt expired at 1446. Death Certificate # provided.
Age: 63.0
Sex: M
Vaccine: PNC20, PNC20
Symptoms: Paraesthesia, Plasmapheresis, Pneumonia aspiration, Pyrexia, Tobacco user
Clinical narrative: On 03/06/24, 63 yo M presented to Medicine clinic as a new patient evaluation. Pt's PMHx included HTN, CVA in 2012, DM-II, dysphagia, pilar cyst, and atherosclerotic PVD with intermittent claudication. During visit, pt was ordered and administered Pneumococcal (PCV20) (>=6WKS) vaccine (Prevnar 20). Per immunization record, pt received 0.5 mL in left deltoid at 1556 (Lot #HG7740, Exp: 4/30/2025, NDC #0005-2000-01). Pt was referred to Vascular Surgery for PVD, GI for dysphagia, and GSU for Pilar cyst. On 03/13, pt seen by Vascular Surgery. Assessment was unremarkable with no recommended intervention for nonlimb threatening right lower extremity claudication. MD did discuss smoking cessation. There was no documentation of any other pt symptoms or problems. On 03/16/24, pt presented to ED with c/o numbness and tingling in lower extremities with difficulty standing/walking. Neurology consulted and MRI ordered. Due to progressing weakness through arms and trunk, pt admitted to ICU for work up for Guillain Barre Syndrome. On 03/17, pt intubated and started on IVIG. 03/18 LP confirmed GBS diagnosis. On 03/20, pt received fourth and final dose of IVIG. Pt offered tracheostomy, but both pt and family declined. Psych and Palliative Care consults completed. Pt's condition continued to decline with new diagnosis of aspiration pneumonia on 03/28. Pt started on antibiotics. PLEX treatment started on 04/02. PLEX stopped on 04/04 due to fever. Pt transitioned to comfort care. Pt expired at 1446. Death Certificate # provided.
Sex: F
Vaccine: HPV9
Symptoms: Expired product administered, No adverse event
Clinical narrative: no AE; inadvertently administered an expired dose of GARDASIL 9; This spontaneous report was received from the patient and referred herself with unknown age. Pertinent medical history, concomitant medications and drug reactions/allergies were not reported.  On 01-APR-2024, the patient inadvertently received an expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided) (expired product administered). No adverse event was reported (no adverse event).
Sex: U
Vaccine: PNC15
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Temperature excursion occurred this morning on 04/03/2024 and vaccine was administered to patient today on 04/03/2024; This spontaneous report has been received from a medical assistant referring a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided.    On 04-MAR-2024, the patient was vaccinated with an improperly stored dose of pneumococcal 15v conj vaccine (CRM197) (VAXNEUVANCE) injection, lot number X022026 with expiration date provided as 02-OCT-2025 that has been verified to be valid with expiration date provided as 22-OCT-2025, administered for prophylaxis (strength, specific dosage, vaccination scheme, route of administration and anatomical site of application were not provided) (product storage error) that on that same date (reported as this morning), the vaccine had a temperature excursion of 58.35F, for a time range between 3 hours 35 minutes 0 seconds. No additional adverse events or product quality complaint were reported. No previous temperature excursion reported.
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pain, Pruritus, Pyrexia, Rash
Clinical narrative: circular rash; painful to touch; itchy; aches; slight fever; swollen; red; This non-serious case was reported by a other health professional via sales rep and described the occurrence of rash in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: circular rash), tenderness (Verbatim: painful to touch), pruritus (Verbatim: itchy), pain (Verbatim: aches), fever (Verbatim: slight fever), swelling (Verbatim: swollen) and erythema (Verbatim: red). The outcome of the rash, tenderness, pruritus, pain, fever, swelling and erythema were not resolved.   The reporter considered the rash, tenderness, pruritus, pain, fever, swelling and erythema to be related to Shingrix.     The company considered the rash, tenderness, pruritus, pain, fever, swelling and erythema to be related to Shingrix.   Additional Information: GSK Receipt Date: 26-MAR-2024 The reporter reported that patient received a dose of Shingrix vaccine. The patient experienced red, circular rash, swollen, painful to touch, itchy, slight fever, aches. The reporter consented to follow up.
Sex: F
Vaccine: VARZOS
Symptoms: Swelling, Tenderness
Clinical narrative: circular rash; painful to touch; itchy; aches; slight fever; swollen; red; This non-serious case was reported by a other health professional via sales rep and described the occurrence of rash in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: circular rash), tenderness (Verbatim: painful to touch), pruritus (Verbatim: itchy), pain (Verbatim: aches), fever (Verbatim: slight fever), swelling (Verbatim: swollen) and erythema (Verbatim: red). The outcome of the rash, tenderness, pruritus, pain, fever, swelling and erythema were not resolved.   The reporter considered the rash, tenderness, pruritus, pain, fever, swelling and erythema to be related to Shingrix.     The company considered the rash, tenderness, pruritus, pain, fever, swelling and erythema to be related to Shingrix.   Additional Information: GSK Receipt Date: 26-MAR-2024 The reporter reported that patient received a dose of Shingrix vaccine. The patient experienced red, circular rash, swollen, painful to touch, itchy, slight fever, aches. The reporter consented to follow up.
Sex: M
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: He has not yet received the 2nd dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (In 2021, received first dose).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: He has not yet received the 2nd dose). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 27-MAR-2024 The reporter reported that the patient received his first dose of Shingrix in 2021, but had not received the 2nd dose of Shingrix yet. The reporter requested to consent to follow-up. Till the time of reporting patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Age: 21.0
Sex: U
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Bexsero was administered to a patient that requires the protection of Menveo for school; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 21-year-old patient who received Men B NVS (Bexsero) for prophylaxis.   On 25-MAR-2024, the patient received Bexsero. On 25-MAR-2024, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: Bexsero was administered to a patient that requires the protection of Menveo for school). The outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 27-MAR-2024 The reporter called and reported that the wrong meningitis vaccine was administered, stated that Bexsero was administered to a patient that required the protection of Menveo for school, which led to wrong vaccine administered. Lot number was not reported. The reporter did not consent to follow-up.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: HCP inquired, "Is second dose of Shingrix valid if it has been 15 months since first dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (On an unknown date received first dose before 15 months from reporting day).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: HCP inquired, "Is second dose of Shingrix valid if it has been 15 months since first dose). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 27-MAR-2024 The health care provider inquired the was second dose of Shingrix valid if it had been 15 months since firs dose. Reporter did not provide any contact, vaccine or patient details. The reporter did not consent to follow-up. Till the time of reporting patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Sex: M
Vaccine: DTAPIPV
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: patient who is 15 months old and they gave Kinrix and should've given Infanrix; patient who is 15 months old and they gave Kinrix and should've given Infanrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 15-month-old male patient who received DTPa-IPV (Kinrix) (batch number 34MF9, expiry date 13-FEB-2026) for prophylaxis.   On 18-MAR-2024, the patient received Kinrix. On 18-MAR-2024, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: patient who is 15 months old and they gave Kinrix and should've given Infanrix) and inappropriate age at vaccine administration (Verbatim: patient who is 15 months old and they gave Kinrix and should've given Infanrix). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 28-MAR-2024 Registered nurse stated that they had a patient who was 15 months old and they gave Kinrix and should had given Infanrix, which led to wrong vaccine administered and inappropriate age at vaccine administration. The vaccine administration facility was same as primary reporter. The reporter consented to follow-up.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Extra dose administered, Fatigue
Clinical narrative: extreme fatigue; received a 3rd dose of SHINGRIX; This non-serious case was reported by a consumer via call center representative and described the occurrence of fatigue in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included fatigue. Previously administered products included Shingrix (on an unknown date received 1st dose two years ago) and Shingrix (on an unknown date received 2nd dose two years ago). Concurrent medical conditions included multiple sclerosis (Multiple Sclerosis fatigue).   In FEB-2024, the patient received the 3rd dose of Shingrix. In FEB-2024, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: received a 3rd dose of SHINGRIX). On an unknown date, the patient experienced fatigue (Verbatim: extreme fatigue). The outcome of the fatigue and extra dose administered were unknown.   It was unknown if the reporter considered the fatigue to be related to Shingrix.     It was unknown if the company considered the fatigue to be related to Shingrix.   Additional Information: GSK Receipt Date: 28-MAR-2024 The patient stated that she received her first two Shingrix doses two years ago at a popular chain pharmacy, where she was told she must return and repeat the series in two years.   Five weeks ago, she went to another store of the same chain and received a 3rd dose of Sjingrix, after reporting to the pharmacist she had already had two doses two years prior.   She reported that she experienced extreme fatigue, much more debilitating than her usual Multiple Sclerosis fatigue for a few days following the third dose 5 weeks ago.  Contact information for the two pharmacies was listed in the call notes section of this report. The patient received 3rd dose of vaccine, which led to extra dose administered.
Age: 75.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered
Clinical narrative: she forgot she had the vaccine so she just got another vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 75-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 4L5M7, expiry date 29-MAR-2025) for prophylaxis.   Previously administered products included Arexvy (In December 2023, received first dose).   On 28-MAR-2024, the patient received the 2nd dose of Arexvy. On 28-MAR-2024, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: she forgot she had the vaccine so she just got another vaccine). The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 28-MAR-2024 The reporter stated that a patient received a dose of Arexvy in December 2023 (exact date not available), but patient forgot she had the vaccine, so she just got another vaccine, which led to extra dose administered. Specialist clarified the second dose was Arexvy, no further details provided. Specialist requested patient initials, but reporter did not provide on the call. Reporter was very busy and kept placing specialist on hold, so requested information was emailed, and reporter granted permission for safety to follow up via mail if needed. The reporter consented to follow-up.
Sex: F
Vaccine: RSV
Symptoms: Dizziness, Syncope
Clinical narrative: fainting; lightheadedness; This serious case was reported by a physician via call center representative and described the occurrence of fainting in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received the 1st dose of Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced fainting (Verbatim: fainting) (serious criteria GSK medically significant) and light headedness (Verbatim: lightheadedness ). The outcome of the fainting was not reported and the outcome of the light headedness was unknown.   It was unknown if the reporter considered the fainting and light headedness to be related to Arexvy.     It was unknown if the company considered the fainting and light headedness to be related to Arexvy.   Additional Information: GSK receipt date: 28-MAR-2024 The provider sent a web form request requesting data about the usage of Arexvy and the incidence of lightheadedness and fainting.  A partial adverse event was collected.
Sex: M
Vaccine: COVID19
Symptoms: Polymyalgia rheumatica
Clinical narrative: polymyalgia rheumatica; This is a literature report.  A 74-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: POLYMYALGIA RHEUMATICA (medically significant), outcome "recovering". Therapeutic measures were taken as a result of polymyalgia rheumatica with Prednisolone and Symptoms improved. No follow-up attempts are possible.; Sender's Comments: The event polymyalgia rheumatica is conservatively assessed as related to the suspect drug BNT162B2 based on close temporal association but consider also possible contributory effects from medical history of the patient and/or concomitant medications. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-PV202400028569 Same article/ drug/ patient and different event (Diffrent dose BNT);
Sex: U
Vaccine: HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired Act-Hib was administered past its expiry date with no reported adverse event; Initial information received on 01-Apr-2024 regarding an unsolicited valid non-serious case received via other health professional.  This case involves an unknown age and unknown gender patient and the reporter stated expired HIB (PRP/T) vaccine [ACT-HIB] was administered past its expiry date with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On 01-Apr-2024, the patient received an unknown dose of suspect HIB (PRP/T) vaccine, Powder and solvent for solution for injection (strength: unknown) (lot: UJ855AB, expiry date: 22-Mar-2024) via unknown route in unknown administration site for prophylactic vaccination (immunization) and expired act-hib was administered past its expiry date with no reported adverse event (expired product administered) (latency: same day)   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Eyelid sensory disorder, Herpes zoster, Hypoaesthesia, Ophthalmic herpes zoster, Pain
Clinical narrative: numbness on the eyelid; numbness of forehead, scalp and eyebrow; Pain like a bad migraine; Patient got the vaccine shot and got shingles/Suspected vaccination failure; Shingles in the eye; shingles on the left side of the upper face; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In MAR-2024, more than a year after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Patient got the vaccine shot and got shingles/Suspected vaccination failure) (serious criteria GSK medically significant), ophthalmic herpes zoster (Verbatim: Shingles in the eye) (serious criteria GSK medically significant) and shingles (Verbatim: shingles on the left side of the upper face). On an unknown date, the patient experienced numbness of eyelid (Verbatim: numbness on the eyelid), numbness (Verbatim: numbness of forehead, scalp and eyebrow) and pain (Verbatim: Pain like a bad migraine). The outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster, shingles, numbness of eyelid and numbness were not reported and the outcome of the pain was not resolved.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, shingles, numbness of eyelid, numbness and pain to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure, ophthalmic herpes zoster, shingles, numbness of eyelid, numbness and pain to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 01-Apr-2024 This case was reported by a patient via interactive digital media. The patient stated that he/she got the 2 shots 2 years ago and in the month of reporting month the patient got shingles on the left side of the upper face and in the eye.  The patient had numbness on the eyelid, eyebrow, forehead and scalp.  The patient also had the pain like a bad migraine at the time of reporting. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Vaccination failure
Clinical narrative: numbness on the eyelid; numbness of forehead, scalp and eyebrow; Pain like a bad migraine; Patient got the vaccine shot and got shingles/Suspected vaccination failure; Shingles in the eye; shingles on the left side of the upper face; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In MAR-2024, more than a year after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Patient got the vaccine shot and got shingles/Suspected vaccination failure) (serious criteria GSK medically significant), ophthalmic herpes zoster (Verbatim: Shingles in the eye) (serious criteria GSK medically significant) and shingles (Verbatim: shingles on the left side of the upper face). On an unknown date, the patient experienced numbness of eyelid (Verbatim: numbness on the eyelid), numbness (Verbatim: numbness of forehead, scalp and eyebrow) and pain (Verbatim: Pain like a bad migraine). The outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster, shingles, numbness of eyelid and numbness were not reported and the outcome of the pain was not resolved.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, shingles, numbness of eyelid, numbness and pain to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure, ophthalmic herpes zoster, shingles, numbness of eyelid, numbness and pain to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 01-Apr-2024 This case was reported by a patient via interactive digital media. The patient stated that he/she got the 2 shots 2 years ago and in the month of reporting month the patient got shingles on the left side of the upper face and in the eye.  The patient had numbness on the eyelid, eyebrow, forehead and scalp.  The patient also had the pain like a bad migraine at the time of reporting. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Age: 36.0
Sex: F
Vaccine: HEPA
Symptoms: Underdose
Clinical narrative: Pediatric dose given instead of Adult dose
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Cough, Dyspnoea, Malaise, Pain
Clinical narrative: General malaise, fevers/chills, congestion, rhinorrhea, cough, shortness of breath, body aches
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: General malaise, fevers/chills, congestion, rhinorrhea, cough, shortness of breath, body aches
Age: 11.0
Sex: M
Vaccine: HPV9, TDAP
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: Arm swollen, red, warm to touch and painful
Age: 53.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Pain in extremity, Pallor, Rash, Rash erythematous
Clinical narrative: Onset soreness of left arm on Friday, redness appeart late in day starting with small areas of redness, then increased over time in size to 5.5 H x 4.5 W x 6.0 D that we see today.  Warm and red, blanches with touch. reported rash as itchy and swollen. no pain at rash site.
Age: 53.0
Sex: F
Vaccine: PNC20
Symptoms: Rash pruritic, Skin warm, Swelling
Clinical narrative: Onset soreness of left arm on Friday, redness appeart late in day starting with small areas of redness, then increased over time in size to 5.5 H x 4.5 W x 6.0 D that we see today.  Warm and red, blanches with touch. reported rash as itchy and swollen. no pain at rash site.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Burning sensation, Dyspnoea, Electrocardiogram, Erythema
Clinical narrative: Pt received his first Moderna vaccine on 3/5/2021. States that immediately after administration, pt experienced burning sensation that radiated from the left upper arm, across the chest and to the face, pt reports associated sob and itching. Symptoms associated with redness. BP was reported as elevated. EMS was called s/p EKG, no medication was given, no epi needed, no transfer to hospital. Pt states that sxs took 2 wks before resolution. Pt was seen by cardiologist who recommended not to complete vaccine series.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Pruritus
Clinical narrative: Pt received his first Moderna vaccine on 3/5/2021. States that immediately after administration, pt experienced burning sensation that radiated from the left upper arm, across the chest and to the face, pt reports associated sob and itching. Symptoms associated with redness. BP was reported as elevated. EMS was called s/p EKG, no medication was given, no epi needed, no transfer to hospital. Pt states that sxs took 2 wks before resolution. Pt was seen by cardiologist who recommended not to complete vaccine series.
Age: 11.0
Sex: M
Vaccine: HPV9, TDAP
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: Arm swollen, red, warm to touch, and painful
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pt was given vaccine that expired 04/06/2024 on 04/08/2024 with no adverse reaction noted. Parent informed and given option to return today or in 1 month for repeat vaccine,  parent declines. Verbalized understanding.
Age: 17.0
Sex: F
Vaccine: HIBV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Pt came in for catch up vaccines and was supposed to receive a HPV but was given a Hib by accident. PT had no symptoms or effects noted. No allergies and no taking any current medications.
Age: 15.0
Sex: M
Vaccine: HIBV
Symptoms: Wrong product administered
Clinical narrative: Pt came in for HPV vaccine but was given HIB on accident. Pt was not currently taking medications or has no allergies.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin, Blood immunoglobulin A decreased, Blood immunoglobulin G decreased, Blood immunoglobulin M increased, Hypoaesthesia
Clinical narrative: May 9 2022 shingles like rash in middle of chest. June 10 5th toe began to get numb on both feet August 5th and 4th toe numb Sept  also top of foot pad Now SpEP blood test:  IgM 1275, IgA  27, IgG 398  whole top of foot-toes and foot pad
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging normal, Positron emission tomogram normal, Rash
Clinical narrative: May 9 2022 shingles like rash in middle of chest. June 10 5th toe began to get numb on both feet August 5th and 4th toe numb Sept  also top of foot pad Now SpEP blood test:  IgM 1275, IgA  27, IgG 398  whole top of foot-toes and foot pad
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Feeling hot, Pain in jaw, Rash, Rash erythematous, Rash macular
Clinical narrative: Patient was administered the vaccine and went home. About 1 and 1/2 hours later, he called the pharmacy to report symptoms of red blotches all over the body (head to toe), including his face. He stated a feeling like he had a sunburn, felt hot, legs hot on "on fire." His jaw feels hurt and achy. He could breathe fine and had no problems with breathing. He said that he took two 25mg Benadryl tablets (total dose of 50mg). He stated that he felt better 15 minutes after taking the Benadryl. He did mention that after he came home, he had injected himself with mounjaro shortly after. I recommended for him to call his Dr or go to the ER, if necessary. His wife is an RN and was with him. I followed up with him a while later and patient said there were no more problems (the blotches went away). The following day, our other pharmacist called to see how he was doing. Patient reports that he is all recovered. His primary MD told him to take Claritin for 5 days to be safe. He had no porblems after his 1st Shingrix or any other previous vaccines. She asked if he changed any medications recently and he said he's on mounjaro from another pharmacy. He was not on it when he got Shingrix dose #1.
Age: 12.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Unevaluable event
Clinical narrative: none
Age: 0.83
Sex: M
Vaccine: UNK
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient was given the diluent and not the vaccine. The diluent was not mixed in the vaccine powdered vial prior to administration therefore not receiving the complete vaccine. Discussed with Menveo manufacture and care team. No adverse reaction.
Age: 56.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Pain
Clinical narrative: Patient reported on 4/4/24 that she is still experiencing pain at her injection site. She stated that it was difficult to elevate her arm up to shoulder level without feeling some pain.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Decreased appetite, Malaise, Myalgia, Nausea
Clinical narrative: musle soreness, arm was killing her on right arm , chills and nausea and didn't want to eat and she didn't feel well she took tylenol . Took a bath and notice a rash right breast in between both breasts simular to shingle reaction last year know it will go away did not see a Dr.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Rash
Clinical narrative: musle soreness, arm was killing her on right arm , chills and nausea and didn't want to eat and she didn't feel well she took tylenol . Took a bath and notice a rash right breast in between both breasts simular to shingle reaction last year know it will go away did not see a Dr.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: unknown adverse event
Age: 60.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Pt experiencing swelling/firmness/redness/warmth at the injection site 4 days after injection.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph node nearest injection site swelled up on the day after the injection.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Atrial fibrillation, Back pain, COVID-19, Encephalopathy
Clinical narrative: Hospitalization for Sepsis, acute encephalopathy, Afib with RVR, AKI, thrombocytopenia, chronic back pain, COVID, history of tobacco abuse, and GERD on dates 3/22/24- 4/3/24. Treated with no COVID medications.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis, Thrombocytopenia
Clinical narrative: Hospitalization for Sepsis, acute encephalopathy, Afib with RVR, AKI, thrombocytopenia, chronic back pain, COVID, history of tobacco abuse, and GERD on dates 3/22/24- 4/3/24. Treated with no COVID medications.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium decreased, Haemoglobin decreased, Haemoglobin increased, Respiratory failure, Urine analysis normal
Clinical narrative: respitory failure
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: respitory failure
Age: 77.0
Sex: M
Vaccine: FLU4
Symptoms: Erythema, Skin discolouration
Clinical narrative: Patient came to the pharmacy days later due to experiencing a local redness and skin color change after receiving the vaccine. He is not sure when it first started to develop, but he has a dark-red circular skin discoloration on his arm. I advised patient to follow up with his medical doctor as soon as possible. He reports that he does not have any anaphylaxis symptoms (no itchiness, swelling, problem breathing, hives, etc.).
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Echocardiogram, Electrocardiogram, Laboratory test, Malaise
Clinical narrative: PFIZER #1 SEP 23 2021 PFIZER #2 OCT 18 2021, DEVELOPED CHEST PAIN, HIGH GRADE VENTRICULAR ECTOPY POTS, SMALL FIBER NEUROPATHY, POST EXERTIONAL MALAISE.  TREATED WITH , BISOPROLOL RAMIPRIL, AND PROTOCOL,  SYMPTOMS SO SEVERE IT FORCED EARLY TERMINATION OF CAREER.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Postural orthostatic tachycardia syndrome, Small fibre neuropathy
Clinical narrative: PFIZER #1 SEP 23 2021 PFIZER #2 OCT 18 2021, DEVELOPED CHEST PAIN, HIGH GRADE VENTRICULAR ECTOPY POTS, SMALL FIBER NEUROPATHY, POST EXERTIONAL MALAISE.  TREATED WITH , BISOPROLOL RAMIPRIL, AND PROTOCOL,  SYMPTOMS SO SEVERE IT FORCED EARLY TERMINATION OF CAREER.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Blood glucose normal, Electrocardiogram T wave abnormal, Loss of consciousness, Malaise, Nausea
Clinical narrative: Patient received vaccine at approximately 09:20-9:30 a.m. on 4/8/24 and then returned to class. Patient appeared healthy and without distress. Classroom teacher reported at approximately at 09:40 that patient had lost consciousness and had a seizure. School Secretary called 911 at this time. Public health nurses reported to patient's classroom and observed him laying on the floor, alert, and oriented. Teacher described that the patient was sitting at his desk and the classroom students were talking about shots. Teacher stated that patient then "passed out" and started to have a seizure. The teacher helped the student to the floor and applied ice packs to his forehead. Patient then gained consciousness. Ambulance arrived shortly after. Vitals assessed as well as an EKG. Ambulance staff stated that the EKG was normal with the exception of some elevation in T waves.  While blood sugar was being assessed, the patient stated that he was feeling sick again, and that another episode was going to occur. Patient proceeded to lose consciousness again and did have a seizure while the ambulance staff were present.   After the patient regained consciousness the paramedic suggested he eat or drink something.  Blood sugar was 72 according to EMT. Patient given nutty bar. He then became nauseous and vomited. Patient also given apple juice and water.  Ambulance staff then assisted the patient to the ambulance. He was able to walk with assistance. Patient then transported to Hospital for evaluation.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Seizure, Vomiting
Clinical narrative: Patient received vaccine at approximately 09:20-9:30 a.m. on 4/8/24 and then returned to class. Patient appeared healthy and without distress. Classroom teacher reported at approximately at 09:40 that patient had lost consciousness and had a seizure. School Secretary called 911 at this time. Public health nurses reported to patient's classroom and observed him laying on the floor, alert, and oriented. Teacher described that the patient was sitting at his desk and the classroom students were talking about shots. Teacher stated that patient then "passed out" and started to have a seizure. The teacher helped the student to the floor and applied ice packs to his forehead. Patient then gained consciousness. Ambulance arrived shortly after. Vitals assessed as well as an EKG. Ambulance staff stated that the EKG was normal with the exception of some elevation in T waves.  While blood sugar was being assessed, the patient stated that he was feeling sick again, and that another episode was going to occur. Patient proceeded to lose consciousness again and did have a seizure while the ambulance staff were present.   After the patient regained consciousness the paramedic suggested he eat or drink something.  Blood sugar was 72 according to EMT. Patient given nutty bar. He then became nauseous and vomited. Patient also given apple juice and water.  Ambulance staff then assisted the patient to the ambulance. He was able to walk with assistance. Patient then transported to Hospital for evaluation.
Age: 59.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Hypoaesthesia, Injected limb mobility decreased, Injection site pain
Clinical narrative: Patient had adverse event with her left arm where she received Adacel injection. Patient stated the Shingrix arm was sore the next day. The Adacel are starting hurting the next day. Painful and Patient stated she did not having feeling in her fingers. She also stated she could not raise her arm. Patient talked to my staff pharmacist first. The patient did not take anything for the pain and discomfort. Patient discussed going to dr to see what they thought about her arm
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Cerebrovascular accident, Chronic kidney disease, Cognitive disorder
Clinical narrative: Hospitalization for acute on chronic HFrEF exacerbation with acute hypoxic respiratory failure, COVID-19 pneumonia, diabetes mellitus, recent CVA, CKD stage four, rapidly progressive cognitive decline on dates 3/29/24- 4/5/2024. Treated with no COVID-19 medications.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Diabetes mellitus, Heart failure with reduced ejection fraction
Clinical narrative: Hospitalization for acute on chronic HFrEF exacerbation with acute hypoxic respiratory failure, COVID-19 pneumonia, diabetes mellitus, recent CVA, CKD stage four, rapidly progressive cognitive decline on dates 3/29/24- 4/5/2024. Treated with no COVID-19 medications.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Dementia, Hyperlipidaemia, Hypertension
Clinical narrative: Hospitalization for acute hypoxic respiratory failure due to COVID-19 pneumonia, physical deconditioning, diabetes mellitus type 2, hypertension, hyperlipidemia, hypothyroidism, dementia on dates . Treated with Remdesivir.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Hypothyroidism, Physical deconditioning, Type 2 diabetes mellitus
Clinical narrative: Hospitalization for acute hypoxic respiratory failure due to COVID-19 pneumonia, physical deconditioning, diabetes mellitus type 2, hypertension, hyperlipidemia, hypothyroidism, dementia on dates . Treated with Remdesivir.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Atrophy, Electromyogram abnormal, Injected limb mobility decreased, Injection site reaction, Laboratory test
Clinical narrative: She got her 3rd vaccine, her arm started getting very weak and progressively went from fingers, to the rest of her hand, wrist and then the lowre part of her arm and the upper part of her arm.  She went to the doctor in April of 2022 and he prescribed PT and it seemed as though at first it was helping, but then the muscle in her left hand just seemed to be going away and then her wrist, and then the lower part of her left arm.  The upper part of her left arm is somewhat affected.  After a year of PT her doctor decided to order an MRI and x-rayed before that, and then she was referred to another doctor and it's been referrals to other doctors ever since.  Then she got referred down to Medical University and she has seen 5 doctors there.  None of them can find anything wrong with her arm.  She has had a whole lot of testing, and now they are going to do some genetic testing on her.  She was not given any medicines to take for her symptoms.  She is just waiting for the genetic testing at this point.  She has another appointment on 4/15/24 with a neurologist, which she has seen 2 other neurologist, she had EMG's from this one and nerve conduction testing, and the testing on the left arm was found to be abnormal.   She can hardly use her arm, she cannot lift anything, it is painful at times, just difficult to use it.  Her arm has atrophied.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Muscle disorder, Muscular weakness, Nerve conduction studies abnormal, Pain in extremity
Clinical narrative: She got her 3rd vaccine, her arm started getting very weak and progressively went from fingers, to the rest of her hand, wrist and then the lowre part of her arm and the upper part of her arm.  She went to the doctor in April of 2022 and he prescribed PT and it seemed as though at first it was helping, but then the muscle in her left hand just seemed to be going away and then her wrist, and then the lower part of her left arm.  The upper part of her left arm is somewhat affected.  After a year of PT her doctor decided to order an MRI and x-rayed before that, and then she was referred to another doctor and it's been referrals to other doctors ever since.  Then she got referred down to Medical University and she has seen 5 doctors there.  None of them can find anything wrong with her arm.  She has had a whole lot of testing, and now they are going to do some genetic testing on her.  She was not given any medicines to take for her symptoms.  She is just waiting for the genetic testing at this point.  She has another appointment on 4/15/24 with a neurologist, which she has seen 2 other neurologist, she had EMG's from this one and nerve conduction testing, and the testing on the left arm was found to be abnormal.   She can hardly use her arm, she cannot lift anything, it is painful at times, just difficult to use it.  Her arm has atrophied.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: She got her 3rd vaccine, her arm started getting very weak and progressively went from fingers, to the rest of her hand, wrist and then the lowre part of her arm and the upper part of her arm.  She went to the doctor in April of 2022 and he prescribed PT and it seemed as though at first it was helping, but then the muscle in her left hand just seemed to be going away and then her wrist, and then the lower part of her left arm.  The upper part of her left arm is somewhat affected.  After a year of PT her doctor decided to order an MRI and x-rayed before that, and then she was referred to another doctor and it's been referrals to other doctors ever since.  Then she got referred down to Medical University and she has seen 5 doctors there.  None of them can find anything wrong with her arm.  She has had a whole lot of testing, and now they are going to do some genetic testing on her.  She was not given any medicines to take for her symptoms.  She is just waiting for the genetic testing at this point.  She has another appointment on 4/15/24 with a neurologist, which she has seen 2 other neurologist, she had EMG's from this one and nerve conduction testing, and the testing on the left arm was found to be abnormal.   She can hardly use her arm, she cannot lift anything, it is painful at times, just difficult to use it.  Her arm has atrophied.
Age: 0.92
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Chest X-ray, Decreased immune responsiveness, Full blood count, Illness, Ultrasound scan
Clinical narrative: Vaccine given while child was I'll and it led to her immune system being low and getting other illness
Age: 0.92
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Urine analysis
Clinical narrative: Vaccine given while child was I'll and it led to her immune system being low and getting other illness
Age: 1.5
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No sings or symtoms
Age: 93.0
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Chills, Malaise
Clinical narrative: Patient phoned in to the pharmacy today to report that she had chills that were so cold even with blankets and she felt sick until Saturday.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Depression, Detoxification, Echocardiogram, Electrocardiogram, Epstein-Barr virus infection reactivation
Clinical narrative: PERICARDITIS, SMALL FIBER NEUROPATHY, EFFORT INTOLERANCE, POST-EXERTIONAL FATIGUE, DEPRESSION WITH SUICIDAL IDEATION, EBV REACTIVATION SYNDROME.  TREATED WITH PROTOCOL
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Exercise tolerance decreased, Fatigue, Laboratory test, Pericarditis, Small fibre neuropathy
Clinical narrative: PERICARDITIS, SMALL FIBER NEUROPATHY, EFFORT INTOLERANCE, POST-EXERTIONAL FATIGUE, DEPRESSION WITH SUICIDAL IDEATION, EBV REACTIVATION SYNDROME.  TREATED WITH PROTOCOL
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Suicidal ideation
Clinical narrative: PERICARDITIS, SMALL FIBER NEUROPATHY, EFFORT INTOLERANCE, POST-EXERTIONAL FATIGUE, DEPRESSION WITH SUICIDAL IDEATION, EBV REACTIVATION SYNDROME.  TREATED WITH PROTOCOL
Age: 18.0
Sex: F
Vaccine: PNC20
Symptoms: Wrong product administered
Clinical narrative: Patient was ordered from provider to receive HPV vaccine. Patient mistakenly received Prevnar 20.
Age: 0.33
Sex: M
Vaccine: HEP, PNC20
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Unfortunately, system was not updated.  No vaccines while in hospoital were entered, though they were documented in discharge summary. He inadvertently, then, received two vaccines which he did not need. Today, reviewed and updated system and he is back on track for vaccines. The provider notified the mother and she was not concerned about the additional vaccinations.   The baby did not experience any adverse effects from the vaccines.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Extra dose administered
Clinical narrative: An additional varicella dose was administered due to inaccurate records.